πŸ›οΈ Verified NIH Record β€’ Updated 2026-08-13

The Ailliance Post-Market Clinical Study (NCT05856370)

The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction

🟒 Recruiting Observational / Diagnostic βš™οΈ Medical Device Protocol Sponsor: Medtronic Spinal and Biologics

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Who can join: Review the eligibility criteria below.

Location: University of Arizona β€” Tucson, Arizona

Age range: 18 Years

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (29 Sites)

Showing the first 25 of 29 sites.

  • University of Arizona β€” Tucson, Arizona
  • OrthoArkansas β€” Little Rock, Arkansas
  • University of California Davis Medical Center β€” Sacramento, California
  • University of California, San Francisco (UCSF) β€” San Francisco, California
  • Indiana University School of Medicine β€” Bloomington, Indiana
  • Indiana Spine Group β€” Carmel, Indiana
  • The Orthopaedic Research Foundation (OrthoIndy) β€” Indianapolis, Indiana
  • Norton Leatherman Spine Specialists β€” Louisville, Kentucky
  • University of Maryland Medical Center β€” Baltimore, Maryland
  • Michigan Orthopaedic & Spine Surgeons β€” Rochester Hills, Michigan
  • University of Minnesota β€” Minneapolis, Minnesota
  • Washington University School of Medicine β€” St Louis, Missouri
  • Washington University School of Medicine β€” St Louis, Missouri
  • Rutgers University Department of Neurosurgery β€” New Brunswick, New Jersey
  • University at Buffalo β€” Buffalo, New York
  • University Hospitals Cleveland Medical Center β€” Cleveland, Ohio
  • The Ohio State University Wexner Medical Center β€” Columbus, Ohio
  • University of Pittsburgh Medical Center UPMC Presbyterian β€” Pittsburgh, Pennsylvania
  • Rhode Island Hospital University Orthopedic β€” Providence, Rhode Island
  • Tennessee Orthopaedic Alliance β€” Nashville, Tennessee
  • American Neurospine Institute, PLLC β€” Frisco, Texas
  • University of Virginia Health System β€” Charlottesville, Virginia
  • Virginia Spine Institute β€” Reston, Virginia
  • Centre Hospitalier Universitaire Dijon Bourgogne β€” Dijon, Bourgogne-Franche-ComtΓ©
  • HΓ΄pital Roger Salengro β€” Lille,

πŸ“ž Contact the Study Coordinator

Phone: (763) 526-8124

Email: lauren.k.oien@medtronic.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Spinal Deformity clinical trials

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—